Document is current
Any future updates will be listed below
-
Authors
Zhou, Mengjiao
Pei, Bing
Cai, Peipei
Yi, Chengxue
Akanyibah, Francis Atim
Lyu, Changkun
-
Funding
Funding for this research was provided by:
Zhenjiang key research and development plan (SH2023050)
- License Information
-
More Information
Article History
Received: 26 October 2024
Accepted: 24 April 2025
First Online: 9 May 2025
Declarations
:
: The ethics of animal research was approved by the Ethical Committee of Jiangsu University. [Approval title: Study on the role and mechanism of exosomes derived from hucMSC in regulating Neddylation in the repair of inflammatory bowel disease.] [Approval number: 2012258] (Approval date: 2020.3.31). The ethics of the human specimens in this study was approved by the Ethics Committee of Zhenjiang First People’s Hospital. [Approval title: Study on the Mechanism of HucMSC-Ex regulating FXR Expression to inhibit Ferroptosis in Repairing IBD.] [Approval number: SQK-20240196-Y] (Approval date: 2024.9.27). And the Original Source (Procell) of THP-1 cells has confirmed initial ethical approval for the collection of human cells, and the donor has signed an informed consent form.
: Not applicable.
: The authors declare that they have no competing interests.
